Medical technology accounts for OECD (Organisation for Economic Co-operation and Development) spending rates differences
This article was originally published in Clinica
Variations in the frequency of use of expensive medical procedures help to explain in part differences in overall healthcare spending between the US and other countries. Indeed, by the end of the last decade, rates of use of coronary artery bypass grafts (CABG) and coronary angioplasty in the US were nearly double those in the next highest user countries, and spending as a percentage of GDP was 13% in the US, nearly double that of other countries.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.